Shareholders of Hungarian drugmaker Gedeon Richter approved a proposal to pay a HUF 100 per-share dividend on last yearʼs earnings at the firmʼs annual general meeting on Wednesday, according to media reports. The dividend fund comes to HUF 18.637 billion.
Last year, shareholders approved a HUF 68 per-share dividend on 2017 earnings.
When determining the dividend, an adjustment was made for losses deriving from regulatory concerns over a potential link with liver injury through use of Richterʼs uterine fibroid drug Esmya, noted a report on business news site mfor.hu.
The consolidated report submitted to the AGM in accordance with International Financial Reporting Standards (IFRS) reveals that the Richter group posted after-tax profit of HUF 36.193 bln in 2018, with a balance sheet footing of HUF 797.883 bln.